EUVIMEDEUVIMED entdecken
Leserbrief

Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant

Erta Rajabi iD, Kousha Farhadi, Mohammadreza Salehi iD

Reviews in Medical Virology · 2026-05 · 36 (3)

DOI: 10.1002/rmv.70150 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Reviews in Medical Virology, online erschienen am 20.04.2026. Verfasst von Erta Rajabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Anesthesia, Critical Care, and Pain Management Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Infectious Diseases, Research Center for Antibiotic Stewardship & Antimicrobial Resistance, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Erta Rajabi, Mohammadreza Salehi

Zitieren

APA

Rajabi, E., Farhadi, K., & Salehi, M. (2026). Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant. Reviews in Medical Virology, 36(3). https://doi.org/10.1002/rmv.70150

Vancouver

Rajabi E, Farhadi K, Salehi M. Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant. Reviews in Medical Virology. 2026;36(3). doi:10.1002/rmv.70150

BibTeX
@article{Rajabi2026,
  author = {Rajabi, Erta and Farhadi, Kousha and Salehi, Mohammadreza},
  title = {Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant},
  journal = {Reviews in Medical Virology},
  year = {2026},
  volume = {36},
  number = {3},
  doi = {10.1002/rmv.70150}
}
Kostenlos starten →